EUVIMEDEUVIMED entdecken
Crossref

Persistent homology analysis of longitudinal computed tomography fibrotic features in COPD

Yusuke Shiraishi iD, Naoya Tanabe iD, Shizuo Kaji iD, Ryo Sakamoto iD, Tomoki Maetani, Yoshihiro Seri, Satoru Terada, Kunihiko Terada, Tsuyoshi Oguma, Motonari Fukui, Shigeo Muro iD, Tomohiro Handa und 2 weitere

European Respiratory Journal · 2026-07 · 68 (1) · 2501630

DOI: 10.1183/13993003.01630-2025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Respiratory Journal, online erschienen am 26.02.2026. Verfasst von Yusuke Shiraishi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Tomography, X-Ray Computed, Pulmonary Emphysema, Lung. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Japan Science and Technology Agency, Moonshot Research and Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Fibrosis may coexist with emphysema in COPD, but computed tomography (CT) quantification is challenging. Persistent homology (PH), a topological data analysis technique, provides interpretable structural features in greyscale images. By using PH, this CT study aimed to quantify fibrotic lesions in nonemphysematous and emphysematous lungs and to investigate clinical implications of PH-based fibrosis quantification in patients with COPD.

Methods

The study included subjects from the Lung Cancer Screening (LCS) cohort (n=346) and two prospective COPD cohorts (Kyoto University n=234; Kyoto-Himeji n=166). Based on CT value patterns and spatial topology, PH assigned each voxel as fibrotic or nonfibrotic and calculated the percentage of fibrotic lung volume (PH-fibrosis%) in association with visually identified interstitial lung abnormality and COPD outcomes.

Results

Higher PH-fibrosis% was associated with interstitial lung abnormalities in the LCS and Kyoto University cohorts. The two COPD cohorts consistently showed significant associations between higher baseline PH-fibrosis% and future exacerbation risk independent of emphysema and airway wall thickness (hazard ratio (HR) 1.39 and 3.35 for Kyoto University and Kyoto-Himeji, respectively). In the Kyoto University cohort, higher PH-fibrosis% was significantly associated with increased mortality (HR 1.94), with a similar trend in the Kyoto-Himeji cohort (HR 1.86). Longitudinal increases in PH-fibrosis% over median 4.98 years were associated with higher exacerbation frequency and patients experiencing greater increase in PH-fibrosis% subsequently exhibited higher mortality in the Kyoto University cohort.

Conclusions

PH can be used to quantify fibrotic lesions on CT and PH-fibrosis% could be a prognostic imaging marker in patients with COPD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveTomography, X-Ray ComputedPulmonary EmphysemaLungPulmonary FibrosisHumansMaleFemaleAgedProspective StudiesMiddle AgedLongitudinal StudiesProportional Hazards ModelsDisease ProgressionPrognosis

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan ntana@kuhp.kyoto-u.ac.jp.
  • Institute of Mathematics for Industry, Kyusyu University, Fukuoka, Japan.
  • Department of Diagnostic Imaging and Nuclear Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Terada Clinic, Respiratory Medicine and General Practice, Himeji, Japan.
  • Department of Respiratory Medicine, Kyoto City Hospital, Kyoto, Japan.

ORCID-Profile: Yusuke Shiraishi, Naoya Tanabe, Shizuo Kaji, Ryo Sakamoto, Shigeo Muro, Susumu Sato, Toyohiro Hirai

Förderung

  • Japan Society for the Promotion of Science
  • Japan Science and Technology Agency
  • Moonshot Research and Development Program

Zitieren

APA

Shiraishi, Y., Tanabe, N., Kaji, S., Sakamoto, R., Maetani, T., Seri, Y., Terada, S., Terada, K., Oguma, T., Fukui, M., Muro, S., Handa, T., Sato, S., & Hirai, T. (2026). Persistent homology analysis of longitudinal computed tomography fibrotic features in COPD. European Respiratory Journal, 68(1), 2501630. https://doi.org/10.1183/13993003.01630-2025

Vancouver

Shiraishi Y, Tanabe N, Kaji S, Sakamoto R, Maetani T, Seri Y, et al. Persistent homology analysis of longitudinal computed tomography fibrotic features in COPD. European Respiratory Journal. 2026;68(1):2501630. doi:10.1183/13993003.01630-2025

BibTeX
@article{Shiraishi2026,
  author = {Shiraishi, Yusuke and Tanabe, Naoya and Kaji, Shizuo and Sakamoto, Ryo and Maetani, Tomoki and Seri, Yoshihiro and Terada, Satoru and Terada, Kunihiko and Oguma, Tsuyoshi and Fukui, Motonari and Muro, Shigeo and Handa, Tomohiro and Sato, Susumu and Hirai, Toyohiro},
  title = {Persistent homology analysis of longitudinal computed tomography fibrotic features in COPD},
  journal = {European Respiratory Journal},
  year = {2026},
  volume = {68},
  number = {1},
  pages = {2501630},
  doi = {10.1183/13993003.01630-2025}
}
Kostenlos starten →